4.7 Article

Multicenter Validation of Abbreviated MRI for Detecting Early-Stage Hepatocellular Carcinoma

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Gastroenterology & Hepatology

Conceptual Model for the Hepatocellular Carcinoma Screening Continuum: Current Status and Research Agenda

Amit G. Singal et al.

Summary: Hepatocellular carcinoma (HCC) has a poor prognosis with survival rates below 20% in 5 years, partly due to failures in the cancer screening process continuum. A conceptual model outlining discrete steps in the HCC screening process highlights delays or failures at each step and identifies factors contributing to these failures at the patient, provider, and health care system levels. Comparing HCC screening processes with breast and colorectal cancer screening can help identify opportunities for improvement and ultimately improve early detection of HCC.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

Article Gastroenterology & Hepatology

Association between ultrasound quality and test performance for HCC surveillance in patients with cirrhosis: a retrospective cohort study

Nicolas Chong et al.

Summary: This study found that impaired ultrasound visualization is associated with worse surveillance test performance in patients with cirrhosis. Severe visual limitations were linked to lower sensitivity, while moderate limitations were associated with an increased risk of false-positive results. Alternative blood-based biomarkers and imaging strategies are needed for patients at risk of ultrasound-based surveillance failure.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

Associations of Ultrasound LI-RADS Visualization Score With Examination, Sonographer, and Radiologist Factors: Retrospective Assessment in Over 10,000 Examinations

David T. Fetzer et al.

Summary: This study identified patient location and sonographer volume as important factors influencing the visualization score of liver ultrasound in HCC screening, which is significant for guiding targeted quality improvement efforts and establishing best practices and performance standards for screening programs.

AMERICAN JOURNAL OF ROENTGENOLOGY (2022)

Article Gastroenterology & Hepatology

HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: A meta-analysis

Amit G. Singal et al.

Summary: In this systematic review and meta-analysis, HCC surveillance was found to be associated with improved early-stage detection, curative treatment receipt, and survival in patients with cirrhosis. However, there was significant heterogeneity in the pooled estimates, and there were fewer data quantifying potential surveillance-related harms. Available data suggest that HCC surveillance is of high value in patients with cirrhosis, although further studies evaluating benefits and harms are still needed.

JOURNAL OF HEPATOLOGY (2022)

Article Gastroenterology & Hepatology

Abbreviated magnetic resonance imaging vs ultrasound for surveillance of hepatocellular carcinoma in high-risk patients

Hyo Jung Park et al.

Summary: By comparing the performance of gadoxetic acid-enhanced abbreviated MRI (AMRI)-based surveillance and ultrasound-only surveillance in high-risk patients for hepatocellular carcinoma (HCC), it was found that AMRI-based surveillance had higher sensitivities and accuracies for early-stage HCC than ultrasound-only surveillance.

LIVER INTERNATIONAL (2022)

Article Gastroenterology & Hepatology

Comparative efficacy of an optimal exam between ultrasound versus abbreviated MRI for HCC screening in NAFLD cirrhosis: A prospective study

Daniel Q. Huang et al.

Summary: This prospective multicenter study compared liver visualization scores of ultrasound (US) and abbreviated hepatobiliary phase (HBP) magnetic resonance imaging (AMRI) in participants with NAFLD cirrhosis. The study found that US had a higher proportion of severe visualisation limitations compared to AMRI. Obesity was identified as an independent predictor for severe visualisation limitation on US. The study suggests reporting US adequacy in clinical studies and considering AMRI for HCC screening when US is suboptimal.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2022)

Article Gastroenterology & Hepatology

Dynamic Changes in Ultrasound Quality for Hepatocellular Carcinoma Screening in Patients With Cirrhosis

Haley Schoenberger et al.

Summary: Nearly 1 in 5 patients with cirrhosis had moderately-severely limited ultrasound visualization for HCC nodules, particularly those with obesity or alcohol-related or nonalcoholic fatty liver disease cirrhosis. Ultrasound quality can change between exams, including improvement in many patients with limited visualization.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

Article Cell Biology

Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer

Daniel Q. Huang et al.

Summary: Liver cancer epidemiology is changing due to factors such as increasing alcohol consumption, rising obesity rates, and advancements in hepatitis B and C treatment. The Global Burden of Disease study estimated global and regional trends in liver cancer burden, revealing a 25% increase in liver cancer deaths between 2010 and 2019. Non-alcoholic steatohepatitis (NASH) and alcohol were found to have the fastest growing death rates, while hepatitis B and C showed declines. Urgent measures are needed globally to address metabolic risk factors and slow the growing burden of NASH-associated liver cancer, particularly in the Americas.

CELL METABOLISM (2022)

Review Radiology, Nuclear Medicine & Medical Imaging

Diagnostic performance of LI-RADS for MRI and CT detection of HCC: A systematic review and diagnostic meta-analysis

Yingying Liang et al.

Summary: LI-RADS >= 3 demonstrates high diagnostic accuracy for HCC, with LR-5 and LR >= 5 showing higher specificity. Further studies are needed to elucidate its value for diagnosing small HCCs.

EUROPEAN JOURNAL OF RADIOLOGY (2021)

Article Medicine, General & Internal

Hepatocellular carcinoma

Josep M. Llovet et al.

Summary: Liver cancer, particularly hepatocellular carcinoma (HCC), poses a significant global health challenge with rising incidence projected to exceed 1 million cases by 2025. Infection by hepatitis B and C viruses remains a major risk factor for HCC, while non-alcoholic steatohepatitis is emerging as a more common risk factor in Western countries. Advances in systemic therapies for HCC, including immunotherapies and targeted therapies, are expected to revolutionize the management of this disease.

NATURE REVIEWS DISEASE PRIMERS (2021)

Review Gastroenterology & Hepatology

Abbreviated MRI for hepatocellular carcinoma screening: A systematic review and meta-analysis

Pankaj Gupta et al.

Summary: Abbreviated MRI (AMRI) is suggested as an alternative for hepatocellular carcinoma (HCC) screening. Our study showed that AMRI has high sensitivity and specificity for HCC screening. Different AMRI protocols have comparable diagnostic performance.

JOURNAL OF HEPATOLOGY (2021)

Article Medicine, General & Internal

Estimated Projection of US Cancer Incidence and Death to 2040

Lola Rahib et al.

Summary: This cross-sectional study projected cancer incidences and deaths in the United States up to 2040. The findings indicate significant changes in the most common cancers by 2040, with breast cancer projected to become the most common cancer and lung cancer remaining the leading cause of cancer-related death.

JAMA NETWORK OPEN (2021)

Review Medicine, General & Internal

Magnetic Resonance Imaging for Surveillance of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis

Dong Hwan Kim et al.

Summary: This meta-analysis demonstrates that surveillance magnetic resonance imaging (sMRI) has good sensitivity for detecting hepatocellular carcinoma (HCC), especially for very early-stage HCC. Abbreviated MRI protocols for HCC surveillance show comparable diagnostic performance to full MRI protocols.

DIAGNOSTICS (2021)

Review Gastroenterology & Hepatology

Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis

Andrew M. Moon et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)

Article Radiology, Nuclear Medicine & Medical Imaging

Abbreviated MRI for Hepatocellular Carcinoma Screening and Surveillance

Julie Y. An et al.

RADIOGRAPHICS (2020)

Article Radiology, Nuclear Medicine & Medical Imaging

Cost-Utility Analysis of Imaging for Surveillance and Diagnosis of Hepatocellular Carcinoma

Paulo Henrique Lima et al.

AMERICAN JOURNAL OF ROENTGENOLOGY (2019)

Article Radiology, Nuclear Medicine & Medical Imaging

Evaluation of an abbreviated screening MRI protocol for patients at risk for hepatocellular carcinoma

Jennifer Y. Lee et al.

ABDOMINAL RADIOLOGY (2018)

Article Gastroenterology & Hepatology

EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

Peter R. Galle et al.

JOURNAL OF HEPATOLOGY (2018)

Article Gastroenterology & Hepatology

Cost-Effectiveness of Risk Score-Stratified Hepatocellular Carcinoma Screening in Patients with Cirrhosis

Nicolas Goossens et al.

CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2017)

Review Medicine, General & Internal

Imaging Techniques for the Diagnosis of Hepatocellular Carcinoma A Systematic Review and Meta-analysis

Roger Chou et al.

ANNALS OF INTERNAL MEDICINE (2015)